[1]BioorganicandMedicinalChemistryLetters,2010,vol.20,p.7283-7287
[2]Patent:WO2010/54279,2010,A1.Locationinpatent:Page/Pagecolumn101
[3]Patent:EP2346857,2019,B1.Locationinpatent:Paragraph0158;0162
[1]Patent:EP2346857,2019,B1
1824073-96-2
69500-53-4 | 4-[4-[(2S)-2-OXIRANYLMETHOXY]-1,2,5-THIADIAZOL-3-YL]-MORPHOLINE | AA005XI4 | MFCD16251480
70097-14-2 | 1-(2-Oxopropyl)indoline-2,3-dione | AA005Y4Z | MFCD00991620
72956-44-6 | O-Desmethyl Carvedilol | AA005YPX | MFCD03701160
73434-12-5 | 3-Chloro-n,2,2-trimethylpropanamide | AA005ZFH | MFCD11053938
954239-74-8 | Methyl 4-bromobenzo[d]oxazole-2-carboxylate | AA00607M | MFCD09832206
927-55-9 | 4-Aminopentan-1-ol | AA006127 | MFCD16251198
7097-89-4 | Ethanamine,2-isothiocyanato-N,N-dimethyl- | AA0061TD | MFCD03147279
7322-88-5 | (+)-O-Acetyl-L-mandelic acid | AA0062O8 | MFCD00064215
6722-54-9 | 1-(2-Methoxy-2-phenylethyl)piperazine | AA0063F2 | MFCD09952415
7254-29-7 | 2-Amino-5-nitropyrimidin-4(1h)-one | AA00648Z | MFCD22495111